Intra-Cellular Therapies (BSP:I2TC34) Cash Flow for Lease Financing : R$0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Intra-Cellular Therapies Cash Flow for Lease Financing?

Intra-Cellular Therapies's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was R$0 Mil. Intra-Cellular Therapies's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was R$0 Mil.

Compared with last quarter (R$0 Mil in Dec. 2023 ), Intra-Cellular Therapies's Cash Flow for Lease Financing remained the same in Mar. 2024 (R$0 Mil).

Intra-Cellular Therapies Cash Flow for Lease Financing Historical Data

The historical data trend for Intra-Cellular Therapies's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intra-Cellular Therapies Cash Flow for Lease Financing Chart

Intra-Cellular Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Lease Financing

Get a 7-Day Free Trial

Intra-Cellular Therapies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-	-	-	-	-

Intra-Cellular Therapies Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

Intra-Cellular Therapies Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Intra-Cellular Therapies's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Intra-Cellular Therapies (BSP:I2TC34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (BSP:I2TC34) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

ITCI:USA ITCI:Mexico 23I:Germany

Address

430 East 29th Street, New York, NY, USA, 10016

Website

https://www.intracellulartherapies.com

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Intra-Cellular Therapies (BSP:I2TC34) Headlines

No Headlines